newsfilter
← Latest News
GlobeNewswire·

PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025

TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB:PHRRF) (CSE:PHRM) ("PharmaTher" or the "Company"), a specialty pharmaceutical company focused on ketamine for unmet medical